InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Helliwell, James Allen. Insider active across 1 company, notably Eupraxia Pharmaceuticals Inc.. Cumulatively, 4 disclosures have been published. Activity tracked since 15 December 2025. The latest transaction was disclosed on 15 June 2026 (50 - Grant of options). Regulator: SEDI. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
James Allen Helliwell is a declarant linked to Eupraxia Pharmaceuticals Inc., where he is listed as 4 - Director of Issuer. The 4 known filings, in the sampled filings from 2025-12-22 to 2026-06-18, concern 56 - Grant of rights transactions, with buy and sell volumes of 0 EUR.